Advocacy intelligence hub — real-time data for patient organizations
University of Malaya — NA
Weill Medical College of Cornell University — PHASE2
Eben Rosenthal — EARLY_PHASE1
Exelixis — PHASE2
University of California, San Francisco
Hospices Civils de Lyon — NA
University Hospital, Montpellier — NA
Centre Hospitalier St Anne
Medical University of Warsaw — NA
RTOG Foundation, Inc. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Prashant Chittiboina, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
📍 Bethesda, Maryland
Thomas Kaley, MD, PharmD
Memorial Sloan Kettering Cancer Center
📍 SHOREWOOD, IL
Stanislaw R. Burzynski, MD, PhD, M.D., Ph.D
Burzynski Research Institute
📍 HOUSTON, TX
Patrick Wen, MD, MD
National Cancer Institute (NCI)
📍 BOSTON, MA
Richard Kocharian, MD, PhD
Ethicon, Inc.
Helen A Shih, MD
Massachusetts General Hospital